We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£515.00
It has never been this cheap. We have no record of a lower price.
£515 today · cheaper than every other day in the last 3 months
The 2023-2028 Outlook for Endometrial Cancer Treatments in India
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 82 days · 82 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 82 days • 1 price levels
Price Analysis
Most common price: £515 (82 days, 100.0%)
Price range: £515 - £515
Price levels: 1 different prices over 82 days
Description
This study covers the latent demand outlook for endometrial cancer treatments across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or union territory and of India as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state, union territory, and city, latent demand estimates are created for endometrial cancer treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of endometrial cancer treatments as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott Laboratories, ARIAD Pharmaceuticals, Becton, Dickinson and Company, F. Hoffmann-La Roche, GlaxoSmithKline, Merck & Company, Novartis, Sanofi, and Siemens Healthineers. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
Product Specifications
- Format
- paperback
- ASIN
- B0BGKZD5QV
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 14 September 2022
- Listed Since
- 28 September 2022
Similar Products You Might Like
99% match
2023-2028 Endometrial Cancer Treatments Outlook - US Market
£520.00
23 Oct 2026
99% match
2023-2028 Endometrial Cancer Treatments Outlook - China
£495.00
22 Oct 2026
99% match
Endometrial Cancer Treatments Outlook Japan 2023-2028
£495.00
22 Oct 2026
99% match
2023 Endometrial Cancer Treatments Report - Global Market Analysis
£795.00
22 Oct 2026
98% match
The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers
£795.00
29 Sep 2026
98% match
The 2023-2028 Outlook for Endometrial Cancer Treatments for US Zip Codes
£490.00
22 Oct 2026
98% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
£515.00
20 Aug 2026
98% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
£520.00
21 Aug 2026
98% match
The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics
£795.00
25 Aug 2026
97% match
The 2013-2018 Outlook for Endometriosis Treatments in the United States
£495.00
14 Aug 2026
97% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
£495.00
25 Aug 2026
97% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
£495.00
17 Sep 2026
97% match
The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City
£795.00
13 Aug 2026
97% match
The 2025-2030 World Outlook for Uterine Cancer Treatments and Diagnostics
Price unavailable
97% match
The 2025-2030 World Outlook for Uterine Cancer Therapeutics and Diagnostics
Price unavailable
97% match
2023 Chemotherapy Endometrial Cancers Report - Global Market Analysis
£795.00
22 Oct 2026
97% match
Cancer of the Uterine Endometrium - Advances and Controversies
IntechOpen
£119.00
22 Sep 2026
97% match
The 2023-2028 Outlook for Gynecologic Oncology in the United States
£520.00
28 Aug 2026
97% match
Recent Advances in Endometrial Cancer
Springer
£72.98
11 Sep 2026
96% match
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes
£490.00
21 Aug 2026
96% match
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
£515.00
03 Oct 2026
96% match
The 2023-2028 Outlook for Cervical Cancer Treatments in India
£515.00
23 Aug 2026
96% match
The 2023-2028 Outlook for Cancer Supportive Care in the United States
£520.00
22 Aug 2026
96% match
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
£520.00
02 Oct 2026